Olema Pharmaceuticals, Inc.

US$7.33As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:OLMAHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (27.87%)
Div yield —
ROE (52.74%)
Biotechnology
Beta (5Y) 2.02
PE TTM —
TSR TTM (18.28%)
Mkt cap US$641.4M
ROIC (35.25%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$9.31
27.07%
(34.73%)
Hold 3|9|12|12|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.19
0.19
0.19
0.20
29.69%
20.38%
22.42%
16.99%
Revenue$M
34.17
33.59
35.34
35.39
11.57%
8.70%
7.96%
6.77%
Peers (US$641.4M)
Cap (US$)
PE
637.7M
—
Capital
TTM
5Y
10Y
Leveragex
3.359
—
—
EBIT/Intx
0.134
0.224
0.219
Own earn%
31.19
172.21
128.03
Sh yield%
46.58
14.87
15.04
Owners
Insiders/Inst%
7.94
58.52
Short interest%
2.17
SBC / revenue%
1.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
23–26
$1 testx
0.0
Incr. ROIC%
15